Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,272 public trials 686 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)

NCT02363751

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • Institut de Cancérologie de l'Ouest-Site Paul Papin Angers, France
  • CHU Besançon Besançon, France
  • Hôpital Saint André Bordeaux, France
  • Centre François Baclesse Caen, France
View all 19 locations
View Trial Details
Completed

A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

NCT02697591

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +36 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.

NCT01783444

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of California at Los Angeles Mattel Children's Hospital Los Angeles, California, United States
  • Sharp Memorial Hospital SharpClinicalOncologyResearch San Diego, California, United States
  • Florida Cancer Specialists Dept of Oncology (2) Fort Myers, Florida, United States
  • Florida Cancer Specialists FL Cancer Specialists Fort Myers, Florida, United States
View all 83 locations
View Trial Details
Completed

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers

NCT02264990

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Clearview Cancer Institute /ID# 131434 Huntsville, Alabama, United States
  • University of South Alabama /ID# 131518 Mobile, Alabama, United States
  • Highlands Oncology Group /ID# 131250 Springdale, Arkansas, United States
  • CBCC Global Research, Inc. at /ID# 132709 Bakersfield, California, United States
View all 140 locations
View Trial Details
Completed

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

NCT03061812

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +12 more
Locations
  • Clearview Cancer Institute /ID# 155873 Huntsville, Alabama, United States
  • Mitchell Cancer Institute /ID# 158151 Mobile, Alabama, United States
  • Carti /Id# 156982 Little Rock, Arkansas, United States
  • Highlands Oncology Group /ID# 155902 Springdale, Arkansas, United States
View all 195 locations
View Trial Details

Related conditions